Top 10 Robotic Surgery Companies in 2021

Surgical robotic systems help to automate the process of surgeons performing minimally invasive surgeries (MIS). The systems consist of equipment, accessories, software, and distinct services. According to Statzon’s analysis from its data providers, the global Surgical Robot market is valued at around 5.4 billion USD.

The advantages of robot-assisted surgeries (RAS) include factors, such as increased efficiency and accuracy, diminished post-surgical complications in patients, along with the decreased risk of infection and blood loss. Other significant benefits contain shorter recovery time, accessibility to distinct body parts, and a lesser number of scars.

Growth in the surgical robot market can be attributed to driving factors, such as increasing demand for healthcare automation, the complexity of surgical procedures, increased funding for medical robot research, the aging population, and the growing number of chronic diseases.

On the contrary, high installation costs, concerns regarding safety, integration issues, and requirements for skilled personnel are some of the factors that challenge the growth of the market.

Nonetheless, the innovations in the surgical robotics industry are expected to reduce the cost of the systems over the coming years. Thus, market penetration is expected to increase over the forecast period until 2028. According to Statzon’s data analysis, the emerging trend is estimated to continue in the future with a CAGR of +13.8% until 2028.

Statzon has collated the following list featuring the Top 10 Robotic Surgery companies in 2021:

1. Medtronic Plc
2. Zimmer Biomet Holdings, Inc.
3. Smith & Nephew plc
4. Intuitive Surgical, Inc.
5. Renishaw plc
6. Accuray, Inc.
7. THINK Surgical, Inc.
8. Auris Health, Inc.
9. Medrobotics Corporation
10. Asensus Surgical, Inc.

The four main business units of Medtronic consist of: the minimally invasive therapies group, the diabetes group, the restorative therapies group, and the cardiac and vascular group. The company’s wide selection of products treats 70 health conditions, including cardiac devices, insulin pumps, surgical tools, and patient monitoring systems.

Medtronic currently offers the Mazor X Stealth Edition robotic guidance platform for spinal surgery, which was co-developed with the previously acquired Mazor Robotics. The platform consists of features, such as customizable implant selection, optimal implant trajectories, and 3D analytics.

According to a Medtech Insight in 2020, Medtronic’s in-house robotic-assisted platform Hugo RAS Surgery System is currently in development. However, its safety and effectiveness are yet to be established. The system is set to rival da Vinci SP by Intuitive Surgical, Inc. Medtronic is also looking to enhance the existing Mazor X robotic system.

The company’s surgical platform da Vinci System has been installed in around 1,500 hospitals in the U.S. Additionally, more than 5,500 da Vinci Systems can be found in hospitals around the world.

There are three surgical system models to choose from:

• Da Vinci Xi features the most advanced instrumentation, vision, and incorporated table motion
• Da Vinci X is the cost-conscious choice with Xi-model’s architecture
• Da Vinci SP for narrow access surgery, with a single arm equipped with multi-articulated instruments and a 3DHD camera

  All of the three systems share the following components, that vary depending on the model: a patient cart, surgeon console, and a vision cart.

Renishaw’s Neuromate robotic system was designed for stereotactic neurosurgery. It is used in procedures, such as electrode implantation procedures for deep brain stimulation (DBS), stereoelectroencephalography (SEEG), along with stereotactic applications in neuroendoscopy, biopsy, and other research applications.

The Neuromate robot provides a steady, rapid, and precise approach to procedures. Neuromate can be used with or without a stereotactic frame, of which the latter is intended for reduced patient trauma. Procedures with the Neuromate robot can be done using local and general anesthesia.

Accuray, Inc. is a radiation oncology company that is a developer and a manufacturer of progressive cancer treatment technologies. The equipment is manufactured in Madison, Wisconsin; Sunnyvale, California; and in Chengdu, China. The company employees more than 900 people globally. Accuray (ARAY) is traded on the Nasdaq-GS.

The CyberKnife Systems are fully robotic systems that deliver SRS and SBRT, which are used to treat several types of cancer and tumors throughout the body. The systems aim to make the patient’s recovery safer, shorter, and more individualized.

CyberKnife tracks, detects, and corrects tumor and patient movement in real-time during the procedure. This process enables the delivery of precise radiation with sub-millimeter accuracy while allowing patients to breathe normally. CyberKnife requires no anesthesia.

THINK Surgical, Inc. is a medical device and technology company.

The company’s surgical system TSolution One is used to carry out total knee arthroplasty (TKA), and it is fully automated. TSolution One consists of two parts: a TPLAN 3D planning workstation and a TCAT computer-assisted tool.

The TPLAN workstation is a computer system that lets the surgeon explore diverse surgical approaches without wasting the time of the patient (and saving time spent in the OR). The TPLAN converts the CT scan of the patient’s joint into a three-dimensional model of the bone. Subsequently, the TCAT computer-assisted tool uses the surgeon’s previously created plan in order to prepare the joint surface and bone cavity. Under the surgeon’s direct control, TCAT uses specialized bone cutters and other hardware to find an optimal fit for the implant.

The MONARCH platform of Auris Health is used for diagnostic and therapeutic bronchoscopy procedures. The platform integrates robotics, micro-instrumentation, endoscope design, sensing, and data science in order to treat lung cancer.

In a company’s study called ‘REACH’, the unique bronchoscope and sheath telescoping design of MONARCH was able to access all 18 segments of the lung. The platform also successfully reached 42 millimeters further on average than a standard thin bronchoscope. Moreover, the platform’s sheath can be bent up to 130 degrees, while the bronchoscope allows further 180 degrees to work with. Advanced mobility is crucial in the surroundings of tortuous, cramped lungs.

The company’s flagship product, Flex Robotic System, assists in minimally invasive surgeries (MIS). The system aids surgeons to reach and visualize anatomical locations that are otherwise hard to reach or thoroughly inaccessible. The entry to these difficult locations is done through small entry points with technology that utilizes a highly articulated multi-linked scope. The tool can be steered along non-linear paths in a way that is not possible with traditional scopes. Once positioned, the tool becomes rigid, forming a stable surgical platform from which the surgeon can pass flexible surgical instruments. The integrated 3D high-definition vision system illustrates the anatomical journey.

The company’s Senhance Surgical System brings digital laparoscopy to patients around the world. The company markets its products in the United States, Europe, Japan, and Russia, among some other countries. The benefits of the Senhance System are saving time and cost comparing to manual laparoscopy. Further benefits include reaching more patients, operating in more diverse settings, and realizing more distinct procedures.

The system gives the surgeon haptic feedback, which increases the sense of pressure and tension when executing a procedure. Moreover, the platform involves a chair that enables the surgeon to be positioned ergonomically throughout the operation. The monitor of the platform offers eye-tracking camera motion with 3D HD visualization.